Literature DB >> 27476122

The Epidemiology of Benign Prostatic Hyperplasia Associated with Lower Urinary Tract Symptoms: Prevalence and Incident Rates.

Kathryn Brigham Egan1.   

Abstract

This article assesses the reported prevalence and incidence rates for benign prostatic hyperplasia and lower urinary tract symptoms (BPH/LUTS) by age, symptom severity, and race/ethnicity. BPH/LUTS prevalence and incidence rates increase with increasing age and vary by symptom severity. The BPH/LUTS relationship is complex due to several factors. This contributes to the range of reported estimates and difficulties in drawing epidemiologic comparisons. Cultural, psychosocial, economic, and/or disease awareness and diagnosis factors may influence medical care access, symptom reporting and help-seeking behaviors among men with BPH/LUTS. However, these factors and their epidemiologic association with BPH/LUTS have not been thoroughly investigated.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aging; Benign prostatic hyperplasia; Incidence; Lower urinary tract symptoms; Prevalence; Prostate disease; Urology

Mesh:

Year:  2016        PMID: 27476122     DOI: 10.1016/j.ucl.2016.04.001

Source DB:  PubMed          Journal:  Urol Clin North Am        ISSN: 0094-0143            Impact factor:   2.241


  92 in total

1.  Prostatic urethral lift for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.

Authors:  Jae Hung Jung; Balaji Reddy; Karen Ann McCutcheon; Michael Borofsky; Vikram Narayan; Myung Ha Kim; Philipp Dahm
Journal:  Cochrane Database Syst Rev       Date:  2019-05-25

2.  Prostate Transition Zone Fibrosis is Associated with Clinical Progression in the MTOPS Study.

Authors:  Jill A Macoska; Kristen S Uchtmann; Glen E Leverson; Kevin T McVary; William A Ricke
Journal:  J Urol       Date:  2019-06-12       Impact factor: 7.450

3.  Statin use and longitudinal changes in prostate volume; results from the REduction by DUtasteride of prostate Cancer Events (REDUCE) trial.

Authors:  Emma H Allott; Ilona Csizmadi; Lauren E Howard; Roberto L Muller; Daniel M Moreira; Gerald L Andriole; Claus G Roehrborn; Stephen J Freedland
Journal:  BJU Int       Date:  2019-09-27       Impact factor: 5.588

4.  A Prospective Study of Physical Activity, Sedentary Behavior, and Incidence and Progression of Lower Urinary Tract Symptoms.

Authors:  Alison M Mondul; Edward Giovannucci; Elizabeth A Platz
Journal:  J Gen Intern Med       Date:  2020-04-28       Impact factor: 5.128

5.  The effect of α-and δ-tocopherol-lipoic acid ester co-drugs on the response of the rabbit bladder to in vitro ischemia/reperfusion.

Authors:  Robert M Levin; Catherine Schuler; Robert E Leggett; Martha A Hass
Journal:  Turk J Urol       Date:  2018-12-20

Review 6.  Epidemiology and treatment modalities for the management of benign prostatic hyperplasia.

Authors:  Soum D Lokeshwar; Benjamin T Harper; Eric Webb; Andre Jordan; Thomas A Dykes; Durwood E Neal; Martha K Terris; Zachary Klaassen
Journal:  Transl Androl Urol       Date:  2019-10

7.  Aquablation of the prostate for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.

Authors:  Eu Chang Hwang; Jae Hung Jung; Michael Borofsky; Myung Ha Kim; Philipp Dahm
Journal:  Cochrane Database Syst Rev       Date:  2019-02-13

8.  Curcumin for the Treatment of Prostate Diseases: A Systematic Review of Controlled Clinical Trials.

Authors:  Mohammad Bagherniya; Gholamreza Askari; Babak Alikiaii; Saeed Abbasi; Davood Soleimani; Thozhukat Sathyapalan; Tannaz Jamialahmadi; Amirhossein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

9.  Increased risk of atrial fibrillation in patients with benign prostatic hyperplasia: A population-based cohort study.

Authors:  Wei-Syun Hu; Cheng-Li Lin
Journal:  Clin Cardiol       Date:  2018-10-02       Impact factor: 2.882

Review 10.  Silodosin for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.

Authors:  Jae Hung Jung; Jiye Kim; Roderick MacDonald; Balaji Reddy; Myung Ha Kim; Philipp Dahm
Journal:  Cochrane Database Syst Rev       Date:  2017-11-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.